In this issue:
Anti-CD30 CAR-T cell therapy confers durable responses in relapsed and refractory HL
Radiation dose reduction in early-stage Hodgkin lymphoma
Interim PET/CT results are prognostic for PFS and OS in geriatric HL
Second autologous stem cell transplantation for relapsed/refractory HL
Salvage AFM13/pembrolizumab combination therapy shows promise in RRHL
Durability of salvage pembrolizumab after brentuximab vedotin failure in cHL
ABVD followed by BV consolidation in newly diagnosed patients with limited-stage HL
Mediastinal bulk prognostic for survival in advanced-stage HL
Checkpoint inhibition prior to haploidentical transplantation safely delays disease progression
ABVD vs escalated BEACOPP in advanced-stage HL
Please login below to download this issue (PDF)